文献速递胸部介入CTMRPET

CT引导下经胸活检中的功能与代谢成像

Functional and metabolic imaging in transthoracic biopsies guided by computed tomography.
PubMed 文献 · Eur Radiol · 2020-01-03

研究评估以DWI-MR的ADC值和PET-CT的SUV值指导肺病灶活检取样,比较高低可疑区域的组织病理结果。DWI-MR组高可疑区ADC中位数1.1×10-3 mm2/s、低可疑区1.8×10-3 mm2/s(p=0.0001),高可疑区全部阳性、低可疑区71.43%阳性(p=0.0184);PET-CT组高、低可疑区阳性率均为76.9%(p=0.0522)。作者认为肿瘤在功能与代谢上存在异质性,并影响组织病理诊断。

要点

  • DWI-MR组高可疑区ADC中位数1.1×10-3 mm2/s,低可疑区1.8×10-3 mm2/s(p=0.0001)。
  • DWI-MR组高可疑区样本全部阳性,低可疑区71.43%阳性(p=0.0184)。
  • PET-CT组高、低可疑区阳性率均为76.9%(p=0.0522)。

核心结论

  • 使用DWI-MR和PET-CT显示肿瘤在功能与代谢上具有异质性,且这种异质性对组织病理诊断有影响。

研究设计与样本

  • 研究论文,评估基于ADC和SUV水平指导肺病灶活检取样后的组织病理结果,样本量原文未报告。
  • 患者分别接受DWI-MR或PET-CT指导的活检,每位患者从两个病灶区域取样,由局部ADC和SUV值定义低可疑区与高可疑区。
  • DWI-MR组病灶大小中位数78.0 mm,PET-CT组病灶大小中位数61.0 mm。

诊断标准与关键数值

  • DWI-MR组高可疑区ADC中位数1.1×10-3 mm2/s,低可疑区ADC中位数1.8×10-3 mm2/s(p=0.0001)。
  • DWI-MR组高可疑区样本全部阳性,低可疑区样本71.43%阳性(p=0.0184)。
  • PET-CT组高可疑区SUV中位数7.1,低可疑区SUV中位数3.9(p=0.0002)。
  • PET-CT组高可疑区和低可疑区样本阳性率均为76.9%(p=0.0522)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: CT-guided biopsy of indeterminate lung lesions sometimes provides insufficient histological results due to tumor necrosis. Functional and metabolic methods such as DWI-MR and PET-CT may help by directing sample collection to a lesion area of greater biological representativeness. The objective is to evaluate the histopathological results based on findings on ADC and SUV levels in lung lesions suspected for primary cancer.

METHODS: Tissue samples were evaluated after undergoing biopsies guided by either DWI-MR or PET-CT findings. In each patient, sample collection from two lesion areas was guided by local ADC and SUV. Values were used to define areas of low vs. high suspicion for cancer.

RESULTS: Patients who underwent DWI-MR had median lesion size of 78.0 mm. Areas of higher suspicion (HSA) had a median ADC of 1.1 × 10-3 mm2/s, while areas of lower suspicion (LSA) had median ADC of 1.8 × 10-3 mm2/s (p = 0.0001). All HSA samples and 71.43% of LSA samples were positive for cancer (p = 0.0184). Patients who performed PET-CT had median lesion size of 61.0 mm. Median SUV was 7.1 for HSA and 3.9 for LSA (p = 0.0002). Positivity for cancer was observed in 76.9% of samples for both HSA and LSA (p = 0.0522).

CONCLUSION: Use of DWI-MR and PET-CT showed that tumors are functional and metabolically heterogeneous and that this heterogeneity has implications for histopathological diagnosis.

KEY POINTS: • Lung cancer is heterogeneous regarding functional and metabolic imaging. • Tumor heterogeneity may have implications in histopathological diagnosis. • Intralesional lower levels of ADC target highly suspected areas with a significant improvement in lung cancer diagnosis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zurstrassen CE, Tyng CJ, Guimarães MD, et al. Functional and metabolic imaging in transthoracic biopsies guided by computed tomography. Eur Radiol. 2020. PMID: 31900696. doi:10.1007/s00330-019-06591-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。